Mitchell L. Krassan

2015

In 2015, Mitchell L. Krassan earned a total compensation of $1M as Executive Vice President and Chief Strategy Officer at TherapeuticsMD, a 137% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$76,478
Option Awards$720,829
Salary$232,388
Other$11,289
Total$1,040,984

Krassan received $720.8K in option awards, accounting for 69% of the total pay in 2015.

Krassan also received $76.5K in non-equity incentive plan, $232.4K in salary and $11.3K in other compensation.

Rankings

In 2015, Mitchell L. Krassan's compensation ranked 7,756th out of 13,638 executives tracked by ExecPay. In other words, Krassan earned more than 43.1% of executives.

ClassificationRankingPercentile
All
7,756
out of 13,638
43rd
Division
Manufacturing
2,941
out of 5,190
43rd
Major group
Chemicals And Allied Products
1,059
out of 1,854
43rd
Industry group
Drugs
854
out of 1,528
44th
Industry
Pharmaceutical Preparations
673
out of 1,182
43rd
Source: SEC filing on April 25, 2017.

Krassan's colleagues

We found four more compensation records of executives who worked with Mitchell L. Krassan at TherapeuticsMD in 2015.

2015

Robert Finizio

TherapeuticsMD

Chief Executive Officer

2015

John Milligan

TherapeuticsMD

Secretary

2015

Daniel Cartwright

TherapeuticsMD

Chief Financial Officer

2015

Michael Donegan

TherapeuticsMD

Vice President - Finance

News

In-depth

You may also like